Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
 
  • Details

Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes

Journal
International Journal of Cancer
Journal Volume
133
Journal Issue
1
Pages
14-20
Date Issued
2013
Author(s)
CHUNG-HSIN CHEN  
Dickman K.G.
CHAO-YUAN HUANG  
Moriya M.
CHIA-TUNG SHUN  
Tai H.-C.
KUO-HOW HUANG  
SHUO-MENG WANG  
YUAN-JU LEE  
Grollman A.P.
YEONG-SHIAU PU  
DOI
10.1002/ijc.28013
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876664185&doi=10.1002%2fijc.28013&partnerID=40&md5=ae6eab9a66c7d158188fdacb64a002d2
https://scholars.lib.ntu.edu.tw/handle/123456789/542094
Abstract
Aristolochic acid (AA), a component of all Aristolochia-based herbal medicines, is a potent nephrotoxin and human carcinogen associated with upper urinary tract urothelial carcinoma (UUC). To investigate the clinical and pathological characteristics of AA-induced UUC, this study included 152 UUC patients, 93 of whom had been exposed to AA based on the presence of aristolactam-DNA adducts in the renal cortex. Gene sequencing was used to identify tumors with A:T-to-T:A transversions in TP53, a mutational signature associated with AA. Cases with both aristolactam-DNA adducts and A:T-to-T:A transversions in TP53 were defined as AA-UUC, whereas patients lacking both of these biomarkers were classified as non-AA-UUC. Cases with either biomarker were classified as possible-AA-UUC. Forty (26%), 60 (40%), and 52 (34%) patients were classified as AA-UUC, possible-AA-UUC and non-AA-UUC, respectively. AA-UUC patients were younger (median ages: 64, 68, 68 years, respectively; p=0.189), predominately female (65%, 42%, 35%, respectively; p=0.011), had more end-stage renal disease (28%, 10%, 12%, respectively; p=0.055), and were infrequent smokers (5%, 22%, 33%, respectively; p=0.07) compared to possible-AA-UUC and non-AA-UUC patients. All 14 patients who developed contralateral UUC had aristolactam-DNA adducts; ten of these also had signature mutations. The contralateral UUC-free survival period was shorter in AA-UUC compared to possible- or non-AA-UUC (p=0.019 and 0.002, respectively), whereas no differences among groups were observed for bladder cancer recurrence. In conclusion, AA-UUC patients tend to be younger and female, and have more advanced renal disease. Notably, AA exposure was associated with an increased risk for developing synchronous bilateral and metachronous contralateral UUC. What's new? Aristolochic acid, a component of all Aristolochia-based herbal medicines, is a potent nephrotoxin and human carcinogen associated with upper urinary tract urothelial carcinoma (UUC). This is the first clinical study to characterize aristolochic acid-induced UUC using two newly developed biomarkers, aristolactam-DNA adducts in renal cortex and a signature TP53 mutation. Aristolochic acid-induced UUC patients tended to be younger than other UUC patients and predominantly female and had more advanced renal disease. AA exposure was associated with an increased risk for developing synchronous bilateral and metachronous contralateral UUC. This pattern distinguishes AA from other carcinogens involved in the etiology of UUC. Copyright ? 2013 UICC.
SDGs

[SDGs]SDG3

Other Subjects
adenosine; aristolochic acid; cytidine; protein p53; uracil; adult; age distribution; aged; article; bladder cancer; cancer recurrence; cancer risk; cancer survival; carcinogen testing; clinical article; controlled study; DNA adduct; female; gene sequence; human; kidney cortex; male; mutational analysis; nephrotoxicity; nucleic acid base substitution; outcome assessment; priority journal; sex difference; smoking; Taiwan; tp53 gene; transitional cell carcinoma; Adenine; Adult; Age Factors; Aged; Aged, 80 and over; Aristolochic Acids; Carcinogens; Carcinoma, Transitional Cell; DNA Adducts; DNA, Neoplasm; Drugs, Chinese Herbal; Female; Heterocyclic Compounds with 4 or More Rings; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Mutagens; Mutation; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Recurrence; Risk Factors; Sequence Analysis, DNA; Sex Factors; Taiwan; Transcriptome; Treatment Outcome; Tumor Suppressor Protein p53; Urologic Neoplasms
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science